Prostate Cancer Clinical Trials in Dallas

Showing 1-20 of 275 trials

WATER IV PCa (AS Sub-study)

NCT07650448

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Localized Prostate Cancer

PROCEPT BioRobotics333 participantsStarted Sep 2026

Chandler, Arizona, United States • Los Angeles, California, United States • Boulder, Colorado, United States +14 more locations

Active Not RecruitingNA< 1 mile

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

NCT03697148

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

Prostate Carcinoma

ECOG-ACRIN Cancer Research Group852 participantsStarted Feb 2019

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • New Haven, Connecticut, United States +41 more locations

WATER IV PCa (AS Sub-study)

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

Prostate Cancer Trials in Other Cities

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

DESTINY-PANTUMOUR04

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Other Conditions in Dallas